Prof. Richard Greil

Professional Experience

  • 2004-now: Head IIIrd Medical Department, Paracelsus Medical University/Uniklinikum Salzburg, Austria
  • 2005-now: Head Austrian Group for Medical Tumor Therapy (AGMT)
  • 2009-now: Vice President Austrian Academy for Sexual Medicine (OESAM)
  • 2013-now: Head Salzburg Cancer Research Institute (SCRI)

Expertise and Research Interests

  • Phase I-III clinical trials in Hematology and Medical Oncology
  • Translational Research in Hematology and Medical Oncology (e.g.immunooncology)
  • Quality of Life Research in Leukemias and solid cancers
  • Fertility aspects and rehabilitation of cancer patients
  • Immunooncology: mechanisms regulating tumor.induced immunosuppression
  • Health care systems: affordability of cancer care development
  • Cancer Care Program Austria: Member of the development team within the Austrian Minisitery of Health and Member of the Oncology advisory
  • Board for the Austrian Minister of Health
  • Ethics in Medicine: previous 8year terms member of the Austrian Bioethic Committee of the Austrian Chancellor

Selected Publications

  1. Moreno C, Greil R, Lancet Oncol. 2019 Jan;20(1):43-56. doi
  2. Borchmann P, Goergen H, Kobe C, Lohri A, Greil R, et al., Lancet. 2018 Dec 23;390(10114):2790-2802
  3. Greil R, Obrtlíková P, et al., Lancet Haematol. 2016 Jul;3(7):e317-29. doi
  4. Foukakis T, von Minckwitz G , et al., JAMA, 2016 Nov 8;316(18):1888-1896.
  5. Behringer K, Goergen H et al., J Clin Oncol. 2016 Dec 20;34(36):4329-4337